These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10095276)

  • 21. Ovarian cancer screening: are there any options?
    Tiffen J; Mahon SM
    Clin J Oncol Nurs; 2005 Jun; 9(3):369-72. PubMed ID: 15973849
    [No Abstract]   [Full Text] [Related]  

  • 22. Can you screen for ovarian cancer?
    Hicks ML; Parham G
    J Natl Med Assoc; 1995 Feb; 87(2):109-12. PubMed ID: 7897681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mass-screening for ovarian cancer].
    Sato S; Higuchi T; Yokoyama Y; Sakamoto T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():601-4. PubMed ID: 15535316
    [No Abstract]   [Full Text] [Related]  

  • 24. Is there any value in bimanual pelvic examination as a screening test.
    Grover SR; Quinn MA
    Med J Aust; 1995 Apr; 162(8):408-10. PubMed ID: 7746172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How appropriate are the american college of radiology appropriateness criteria for ovarian cancer screening.
    Dubinsky TJ
    Ultrasound Q; 2010 Dec; 26(4):225-6. PubMed ID: 21084937
    [No Abstract]   [Full Text] [Related]  

  • 26. Ovarian cancer screening and mortality.
    Menon U; Gentry-Maharaj A; Jacobs I
    JAMA; 2011 Oct; 306(14):1544; author reply 1544-5. PubMed ID: 21990294
    [No Abstract]   [Full Text] [Related]  

  • 27. Ovarian cancer screening. American College of Radiology. ACR Appropriateness Criteria.
    Böhm-Vélez M; Mendelson E; Bree R; Finberg H; Fishman EK; Hricak H; Laing F; Sartoris D; Thurmond A; Goldstein S
    Radiology; 2000 Jun; 215 Suppl():861-71. PubMed ID: 11037511
    [No Abstract]   [Full Text] [Related]  

  • 28. Screening the postmenopausal ovary.
    Nachtigall LE
    Menopause; 2009; 16(6):1092. PubMed ID: 19779315
    [No Abstract]   [Full Text] [Related]  

  • 29. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian cancer screening.
    Rosenthal A; Jacobs I
    Semin Oncol; 1998 Jun; 25(3):315-25. PubMed ID: 9633843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACR appropriateness criteria© ovarian cancer screening.
    Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
    Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of abdominal and bimanual pelvic examination and transvaginal ultrasonography on serum CA-125 levels.
    Sari R; Buyukberber S; Sevinc A; Ates M; Balat O; Hascalik S; Turk M
    Clin Exp Obstet Gynecol; 2000; 27(1):69-71. PubMed ID: 10758808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for ovarian cancer. We now need a definitive randomised trial.
    Urban N
    BMJ; 1999 Nov; 319(7221):1317-8. PubMed ID: 10567117
    [No Abstract]   [Full Text] [Related]  

  • 34. Ovarian cancer: screening and early detection.
    Goff BA
    Obstet Gynecol Clin North Am; 2012 Jun; 39(2):183-94. PubMed ID: 22640710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of screening for ovarian cancer.
    Westhoff C
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S34-7. PubMed ID: 7835807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. By the way, doctor. I received a widely circulated e-mail message about use of the CA-125 blood test in screening for ovarian cancer. The message suggested that the CA-125 test be used for routine screening, like a Pap smear. Do you agree? What's your opinion of this test?
    Robb-Nicholson C
    Harv Womens Health Watch; 2001 Jul; 8(11):8. PubMed ID: 11511469
    [No Abstract]   [Full Text] [Related]  

  • 37. Reducing ovarian cancer death rates through screening.
    Hartge P
    Cancer; 2011 Feb; 117(3):449-50. PubMed ID: 21254048
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical problem-solving: hypereosinophilic syndrome.
    Hassell LA
    N Engl J Med; 1996 Feb; 334(8):539; author reply 540. PubMed ID: 8559221
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor marker trends in asymptomatic women at risk for ovarian cancer: relevance for ovarian cancer screening.
    Cane P; Azen C; Lopez E; Platt LD; Karlan BY
    Gynecol Oncol; 1995 May; 57(2):240-5. PubMed ID: 7729742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum CA-125 levels: hepatitis or ascites?
    Sevinc A; Buyukberber S; Sari R
    Gynecol Oncol; 2000 Jan; 76(1):141-2. PubMed ID: 10620461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.